Efficacy and tolerability of candesartan cilexetil in hypertensive, type II diabetic patients presenting with diabetic nephropathy (the 'decade' study)

被引：0
|
作者：
Mimran, A [1 ]
Nisse-Durgeat, S [1 ]
机构：
[1] Lapeyronie Hosp, Montpellier, France
来源：
JOURNAL OF HYPERTENSION | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [21] Efficacy and tolerability of candesartan cilexetil vs physician's choice:: The real life study
    Carruthers, S
    Vint-Reed, C
    Investigators, R
    JOURNAL OF HYPERTENSION, 2000, 18 : S160 - S160
  • [22] CONCERNS ABOUT DIABETIC NEPHROPATHY IN THE TREATMENT OF DIABETIC HYPERTENSIVE PATIENTS
    TOLINS, JP
    RAU, L
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (6A): : S29 - S33
  • [23] Comparison between the angiotensin II receptor antagonist candesartan cilexetil and the angiotensin-converting enzyme inhibitor trandolapril in microalbuminuria of patients with early diabetic nephropathy
    Nakamura, T
    Ushiyama, C
    Suzuki, S
    Shimada, N
    Sekizuka, K
    Ebihara, I
    Takahashi, Y
    Tanaka, A
    Koide, H
    NEPHRON, 2000, 86 (02): : 247 - 247
  • [24] Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
    Kume, Shinji
    Uzu, Takashi
    Takagi, Chieko
    Kondo, Morihiro
    Okabe, Tomoko
    Araki, Shin-ichi
    Isshiki, Keiji
    Takeda, Naoko
    Kondo, Keiko
    Haneda, Masakazu
    Koya, Daisuke
    Nishio, Yoshihiko
    Kashiwagi, Atsunori
    Maegawa, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (03) : 298 - 301
  • [25] Efficacy and safety of candesartan cilexetil in elderly hypertensive patients uncontrolled with monotherapy or untreated. The chance study
    Asmar, R.
    Nisse-Durgeat, S.
    JOURNAL OF HYPERTENSION, 2006, 24 : S83 - S83
  • [26] Diabetic nephropathy in type II diabetes
    Ritz, E
    Stefanski, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (02) : 167 - 194
  • [27] The impact of serum bilirubin on diabetic nephropathy and pulmonary function in type II diabetic patients
    Al-Ghuraibawi, Nibras H. Abdulsada
    Al-Mudhafer, Zahraa A.
    Mohammed, Salam J.
    PHYSIOLOGY AND PHARMACOLOGY, 2019, 23 (04): : 322 - 329
  • [28] Environmental Lead Exposure Accelerates Progressive Diabetic Nephropathy in Type II Diabetic Patients
    Huang, Wen-Hung
    Lin, Ja-Liang
    Lin-Tan, Dan-Tzu
    Hsu, Ching-Wei
    Chen, Kuan-Hsing
    Yen, Tzung-Hai
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [29] Efficacy and tolerability of candesartan cilexetil monotherapy or in combination with other antihypertensive drugs - Results of the AURA study
    Schulte, KL
    Fischer, M
    Lenz, T
    Meyer-Sabellek, W
    CLINICAL DRUG INVESTIGATION, 1999, 18 (06) : 453 - 460
  • [30] Progression of diabetic nephropathy in type 1 diabetic patients
    Najafian, Behzad
    Mauer, Michael
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 1 - 8
12345